Effectiveness, persistence of use, and safety of orlistat and liraglutide in a group of patients with obesity.

Luis Fernando Valladales-Restrepo,Nicolás Sánchez-Ramírez,Andrés Felipe Usma-Valencia,Andrés Gaviria-Mendoza,Manuel Enrique Machado-Duque,Jorge Enrique Machado-Alba

Expert opinion on pharmacotherapy（2023）

引用 2|浏览0

暂无评分

摘要

Orlistat and liraglutide users presented weight loss at 12-16 weeks. However, this effect was greater and sustained with liraglutide, especially when combined with physical activity.

查看译文

关键词

(MeSH): liraglutide,obesity,orlistat,pharmacoepidemiology,pharmacovigilance,weight loss

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要